HHS Rulemaking On Price Disclosures In DTC Ads Supported In Senate-Passed Bill

US congressional action comes as HHS forwards proposed rule on enhancing drug pricing transparency to Office of Management and Budget for review.

As seen on tv with retro television icon

More from Pricing Debate

More from Market Access